IO Biotech Inc. Common Stock is a biomedical company specializing in cancer immunotherapies. Their cutting-edge treatments aim to harness the power of the patient’s immune system to fight cancer. With a strong focus on innovation and research, IO Biotech is poised to make significant advancements in the field.
